Akira Teramoto - Concepedia

Author

Akira Teramoto

Nippon Medical School

Also Known As

AKIRA TERAMOTO, Akira TERAMOTO, Akira Teramoto, Shokei Yamada, Teramoto Akira, Teramoto, Akira M.D., Ph.D.

279

Publications

5.1K

Citations

H-Index

172

Concepts

All Affiliations

Nippon Medical School Tokai University Chiba Hokusou Hospital Nippon Medical School Hospital Toranomon Hospital

About

Akira Teramoto is an author at Nippon Medical School specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	93	2.9K
2	Health Sciences	9	9	240
3	Public Health	4	4	111
4	Education	2	2	43
5	Engineering	1	1	25

Akira Teramoto

137

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades Maode Wang, Tuo Wang, Shuoxun Liu, Brain Tumor Pathology Matrix Metalloproteinase-2 And-9Neuro-oncologyTumoral PathologyTumor InnervationGlioma	2003	213
DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors T Hirohata, Kenichiro Asano, Yoshikazu Ogawa, The Journal of Clinical Endocrinology & Metabolism	2013	122
Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma Naoko Sanno, Akira Teramoto, R. Yoshiyuki Osamura Journal of neurosurgery	2000	115
Hypoxia Inducible Factor 1-α Regulates of Platelet Derived Growth Factor-B in Human Glioblastoma Cells Daizo Yoshida, Kyongson Kim, Masahiro Noha, Journal of Neuro-Oncology Blood PlateletHuman Glioblastoma CellsImmunologyHematologyBlood Cell	2005	94
Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas Kyongsong Kim, Keiko Arai, Naoko Sanno, Clinical Endocrinology	2001	72
An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency Kazuo Chihara, Ekaterina Koledova, Akira Shimatsu, European Journal of Endocrinology	2005	71
Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index Masaki Uematsu, Ikuroh Ohsawa, Toshiyuki Aokage, Journal of Neuro-Oncology Tumor BiologyNeuro-oncologyTumoral PathologyTumor InnervationGlioma	2005	68
Inactivation of the Tumor Suppressor Gene on 11q13 in Brothers with Familial Acrogigantism without Multiple Endocrine Neoplasia Type 1<sup>1</sup> Shozo Yamada, Katsuhiko Yoshimoto, Toshiaki Sano, The Journal of Clinical Endocrinology & Metabolism Tumor BiologyGenetic DisorderMedicineGeneticsFamilial Acrogigantism	1997	66
Expression of Wnt4 in Human Pituitary Adenomas Regulates Activation of the β-Catenin-Independent Pathway Takashi Miyakoshi, Mao Takei, Hanako Kajiya, Endocrine Pathology Systems BiologyDevelopmental BiologyPituitary GlandGene Expressionβ-Catenin-independent Pathway	2008	63
Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth Jun Kouno, Hisaki Nagai, Takemitsu Nagahata, Journal of Neuro-Oncology Neuro-oncologySignaling PathwayCc ChemokineGliomaCell Regulation	2004	61

Page 1